UK report recommends better planning for phase I drug trials

被引：1
|
作者：
Mayor, Susan
机构：
来源：
BRITISH MEDICAL JOURNAL | 2007年 / 334卷 / 7593期
关键词：
D O I：
10.1136/bmj.39153.352234.DB
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：551 / 551
页数：1
相关论文
共 50 条
  • [21] Phase I and phase II clinical trials in sarcoma: Implications for drug discovery and development
    Lee, Daniel Y.
    Staddon, Arthur P.
    Shabason, Jacob E.
    Sebro, Ronnie
    [J]. CANCER MEDICINE, 2019, 8 (02): : 585 - 592
  • [22] Escalation with overdose control for phase I drug-combination trials
    Shi, Yun
    Yin, Guosheng
    [J]. STATISTICS IN MEDICINE, 2013, 32 (25) : 4400 - 4412
  • [23] Phase I/II adaptive design for drug combination oncology trials
    Wages, Nolan A.
    Conaway, Mark R.
    [J]. STATISTICS IN MEDICINE, 2014, 33 (12) : 1990 - 2003
  • [24] New Results Will Change the Paradigm for Phase I Trials and Drug Approval
    Chabner, Bruce A.
    [J]. ONCOLOGIST, 2010, 15 (10): : 1023 - 1025
  • [25] Phase I Trials
    Shader, Richard I.
    [J]. CLINICAL THERAPEUTICS, 2014, 36 (04) : 459 - 459
  • [26] PHASE-I AND PHASE-II OF THE CLINICAL-TRIALS FOR A NEW ANTIARRHYTHMIC DRUG
    JAILLON, P
    [J]. THERAPIE, 1986, 41 (02): : 81 - 86
  • [27] Investigational drug therapies in phase I and phase II clinical trials for alcohol use disorders
    Walker, Leigh C.
    Lawrence, Andrew J.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (08) : 677 - 690
  • [28] dfcomb: An R-package for phase I/II trials of drug combinations
    Riviere, Marie-Karelle
    Jourdan, Jacques-Henri
    Zohar, Sarah
    [J]. COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE, 2016, 125 : 117 - 133
  • [29] Potent new hepatitis C drug shows potential in Phase I trials
    不详
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (05) : 531 - 531
  • [30] Quality of phase I clinical drug trials: Influence of organizational management factors
    Zhao, Yang
    Yang, Qiuxia
    Zhang, Xinping
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (05) : 968 - 975
12345